Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease

[1]  R. Hoffman,et al.  T cells in the pathogenesis of systemic lupus erythematosus. , 2004, Frontiers in bioscience : a journal and virtual library.

[2]  Aaron J. Johnson,et al.  Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. , 2002, The Journal of clinical investigation.

[3]  Lieping Chen,et al.  Administration of Agonistic Anti-4-1BB Monoclonal Antibody Leads to the Amelioration of Experimental Autoimmune Encephalomyelitis1 , 2002, The Journal of Immunology.

[4]  K. Tamada,et al.  The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. , 2001, The Journal of clinical investigation.

[5]  J. Peschon,et al.  Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients1 , 2001, The Journal of Immunology.

[6]  A. Sharpe,et al.  Autoantibody Responses and Pathology Regulated by B7-1 and B7-2 Costimulation in MRL/lpr Lupus1 , 2000, The Journal of Immunology.

[7]  C. Smythe,et al.  Treatment of murine lupus with cDNA encoding IFN-?R/Fc , 2000 .

[8]  B. Kwon,et al.  4-1BB: Still in the Midst of Darkness , 2000, Molecules and cells.

[9]  Y. Shoenfeld,et al.  Dichotomic effects of IFN‐γ on the development of systemic lupus erythematosus‐like syndrome in MRL‐lpr / lpr mice , 2000 .

[10]  D. Kono,et al.  Treatment of murine lupus with cDNA encoding IFN-γR/Fc , 2000 .

[11]  R. Mittler,et al.  Anti–4-1bb Monoclonal Antibodies Abrogate T Cell–Dependent Humoral Immune Responses in Vivo through the Induction of Helper T Cell Anergy , 1999, The Journal of experimental medicine.

[12]  A. Theofilopoulos,et al.  Tumour necrosis factor and other cytokines in murine lupus , 1999, Annals of the rheumatic diseases.

[13]  P. Marrack,et al.  Reactive oxygen species regulate activation-induced T cell apoptosis. , 1999, Immunity.

[14]  S. Datta,et al.  Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. , 1999, Journal of immunology.

[15]  M. S. Williams,et al.  Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. , 1998, Journal of immunology.

[16]  Lieping Chen,et al.  NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. , 1998, Cellular immunology.

[17]  B. Kwon,et al.  Role of 4-1BB in immune responses. , 1998, Seminars in immunology.

[18]  A. Schwarting,et al.  IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. , 1998, Journal of immunology.

[19]  S. Kalled,et al.  Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. , 1998, Journal of immunology.

[20]  D. Balomenos,et al.  Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. , 1998, The Journal of clinical investigation.

[21]  S. Nagata,et al.  Why do defects in the Fas-Fas ligand system cause autoimmunity? , 1997, The Journal of allergy and clinical immunology.

[22]  A. Aruffo,et al.  4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses , 1997, The Journal of experimental medicine.

[23]  B. Ryffel,et al.  IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. , 1997, Journal of immunology.

[24]  Lieping Chen,et al.  Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors , 1997, Nature Medicine.

[25]  J. Moslehi,et al.  Roles of interferon-gamma and interleukin-4 in murine lupus. , 1997, The Journal of clinical investigation.

[26]  A. Marshak‐Rothstein,et al.  Unique site of IgG2a and rheumatoid factor production in MRL/lpr mice , 1997, Immunological reviews.

[27]  C. Mohan,et al.  Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. , 1995, Journal of immunology.

[28]  G. Sutherland,et al.  Moslecular and biological characterization of human 4‐1BB and its ligands , 1994, European journal of immunology.

[29]  P. Linsley,et al.  Treatment of murine lupus with CTLA4Ig. , 1994, Science.

[30]  K. Pollok,et al.  4‐1BB T‐cell antigen binds to mature B cells and macrophages, and costimulates anti‐μ‐primed splenic B cells , 1994, European journal of immunology.

[31]  N. Copeland,et al.  Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor , 1993, European journal of immunology.

[32]  S. Nagata,et al.  Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Pollok,et al.  Inducible T cell antigen 4-1BB. Analysis of expression and function. , 1993, Journal of immunology.

[34]  H. Colten,et al.  Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis. , 1988, The Journal of clinical investigation.

[35]  C. Nathan,et al.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.

[36]  R. Hardy,et al.  The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on "helper" T cells that is involved in the response to class II major histocompatibility antigens. , 1984, Journal of immunology.

[37]  R. Coffman,et al.  Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset. , 1982, Journal of immunology.

[38]  A. Theofilopoulos,et al.  Etiopathogenesis of Murine SLE 1 , 1981 .

[39]  A. Theofilopoulos,et al.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains , 1978, The Journal of experimental medicine.

[40]  J. Altman,et al.  In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses , 2002, Nature Immunology.

[41]  R. Wüthrich,et al.  Cytokines in the pathogenesis of systemic lupus erythematosus. , 1999, Seminars in nephrology.

[42]  A. Zeiher,et al.  Nitric oxide and apoptosis. , 1999, Vitamins and hormones.

[43]  D. Wofsy.  Treatment of murine lupus with anti-CD4 monoclonal antibodies. , 1993, Immunology series.

[44]  R. Eisenberg,et al.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.

[45]  A. Theofilopoulos,et al.  Etiopathogenesis of murine SLE. , 1981, Immunological reviews.